FDA launches safety review of two RSV drugs for infants as Kennedy scrutinizes immunizations

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...
Becker's Hospital Review

FDA to reexamine infant RSV therapies

FDA reexamine infant RSV therapies with Sanofi, AstraZeneca, and Merck amid safety concerns and data review under new FDA leadership.

I paid $1,500 to save my thinning hair. Was it worth it?

When stress triggered sudden hair loss, over-the-counter vitamins weren't cutting it. Desperate, I turned to Dr. Hair 90210 ...